Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
Cell therapy holds promise in improving outcomes for many difficult-to-treat diseases. However, this therapeutic strategy also comes with challenges that limit rollouts on a more impactful scale. Cell ...
DURHAM, N.C. & CARLSBAD, Calif.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Argonaut Manufacturing ...
World Construction Network on MSN
CAT and NVIDIA boost partnership to speed up AI solution development
Caterpillar (CAT) has expanded its partnership with NVIDIA to accelerate the development of AI-enabled solutions across its ...
MIAMI--(BUSINESS WIRE)--OrganaBio, LLC, announces initiation of GMP manufacturing operations at its new cell therapy manufacturing facility, launching a new paradigm in contract and development ...
Abzena and France-based Mabqia greed to collaborate on the integration of Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, a project designed to offer ...
GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and formulation capabilities with the launch of a GMP-like mRNA manufacturing service, ...
Microbial systems offer distinct advantages in protein expression, saving costs and time, and offering well-characterized host genetics and ease of scale-up. 2 However, challenges remain in process ...
Health technology company Philips is investing more than $150 million in manufacturing and research and development in the U.S. and is expanding manufacturing facilities in Pennsylvania and Minnesota.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback